Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases (ZFNs)
Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
Roots
Analysis is pleased to announce the publication of its recent
study, titled, “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030.”
The report features an extensive study on the
contract service providers within the biopharmaceutical industry. The study
features in-depth analysis, highlighting the capabilities of a diverse set of
biopharmaceutical CMOs and CDMOs. Amongst other elements, the report includes:
§ A
detailed review of the overall landscape of the biopharmaceutical contract
manufacturing market, featuring a comprehensive list of active
CMOs and detailed analysis of the manufacturing service providers based on a
number of parameters.
§ Elaborate
profiles of key players that have a diverse range of capabilities for the
development, manufacturing, and packaging of biologics.
§ A
detailed discussion on the key enablers in this domain, including certain niche
product classes, which are likely to have a
significant impact on the growth of the contract services market.
§ A case
study on the growing global biosimilars market, highlighting the opportunities
for biopharmaceutical CMOs and CDMOs.
§ A case
study comparing the key characteristics of large molecule and small molecule
drugs, along with details on the various steps involved in their respective
manufacturing processes.
§ A
discussion on challenges related to in-house manufacturing, featuring a brief
overview of the various parameters that a drug / therapy developer may need to
take into consideration while deciding whether to manufacture its products
in-house or outsource.
§ An
analysis of the recent collaborations (signed since 2013) focused on the contract
manufacturing of biologics.
§ A
detailed analysis of the various mergers and acquisitions that have taken place
in this domain, highlighting the trend in the number of companies acquired
between 2013-2018, along with the geographical distribution of this activity.
§ An
in-depth analysis of more than 490 grants that have been awarded to research
institutes engaged in next generation immune checkpoint therapy-related
projects.
§ An
analysis on the recent trends within biopharmaceutical contract manufacturing
industry, highlighting various facility and capability expansions.
§ A
detailed capacity analysis, taking into consideration the individual
development and manufacturing capacities of various stakeholders.
§ A
detailed capacity analysis, taking into consideration the individual
development and manufacturing capacities of various stakeholders.
§ A
discussion on affiliated trends, key drivers, and challenges, under a
comprehensive SWOT framework.
§ A
survey analysis featuring inputs solicited from various experts who are
directly / indirectly involved in providing CMO services to medical device
developers.
§ A detailed market forecast, featuring
analysis of the current and projected future opportunity across key market
segments (listed below)
§ Commonly
Outsourced Business Operations
§ Active
Pharmaceutical Ingredients (API)
§ Finished
Dosage Formulations (FDF)
§ Types
of Expression System
§ Mammalian
§ Microbial
§ Others
§ Company
Size
§ Small
§ Mid-Sized
§ Large
and Very Large
§ Scale
of Operation
§ Preclinical
§ Clinical
§ Commercial
§ Key
Geographical Region
§ North
America
§ Europe
§ Asia-Pacific
§ Rest
of the World
The report also features
detailed transcripts of discussions held with the following experts:
§ Astrid
Brammer, Senior Manager Business Development, Richter-Helm Mathias Schmidt
(Chief Executive Officer, ArmaGen)
§ Birgit
Schwab, Senior Manager Strategic Marketing, Rentschler Biotechnologie
§ Christian
Bailly, Director of CDMO, Pierre Fabre
§ Claire
Otjes, Assistant Marketing Manager, Batavia Biosciences
§ David
C Cunningham, Director Corporate Development, Goodwin Biotechnology
§ Dietmar
Katinger, Chief Executive Officer, Polymun Scientific
§ Denis
Angioletti, Chief Commercial Officer, Cerbios-Pharma
§ Jeffrey
Hung, Chief Commercial Officer, Vigene Biosciences
§ Kevin
Daley, Director Pharmaceuticals, Novasep
§ Mark
Wright, Site Head, Grangemouth, Piramal Healthcare
§ Nicolas
Grandchamp, R&D Leader, GEG Tech
§ Raquel
Fortunato, Chief Executive Officer, GenIbet Biopharmaceuticals
§ Sebastian
Schuck, Head of Business Development, Wacker Biotech
§ Stephen
Taylor, Senior Vice President Commercial, FUJIFILM Diosynth Biotechnologies
§ Tatjana
Buchholz, Marketing Manager, PlasmidFactory and Marco Schmeer, Project Manager,
PlasmidFactory
§ Tim
Oldham, Chief Executive Officer, Cell Therapies
Key
companies covered in the report
§ 3P
Biopharmaceuticals
§ Abzena
§ Albany
Molecular Research
§ BioVectra
§ BioXcellence
(Boehringer Ingelheim)
§ Celonic
§ Charles
River Laboratories
§ ChemPartner
§ Cobra
Biologics
§ CordenPharma
§ Cytovance
Biologics
§ GE
Healthcare
§ Goodwin
Biotechnology
§ Grand
River Aseptic Manufacturing
§ IDT
Biologika
§ KBI BioPharma
§ Kemwell
Biopharma
§ LFB
Biomanufacturing
§ Meridian
Life Science
§ Patheon
§ Pfizer
CentreOne
§ PX'Therapeutics
§ Samsung
BioLogics
§ Sanofi,
CEPiA
§ Thermo
Fisher Scientific
§ Vetter
Pharma International
For
more information please click on the following link:
Biopharma
Contract Manufacturing Market (3rd Edition), 2019-2030
Other Recent Offerings
1.
Cell Therapy Manufacturing Market (3rd Edition), 2019-2030
2.
Antibody Contract Manufacturing Market, 2020-2030
3.
China Biopharmaceutical Contract
Manufacturing Market, 2020-2030
4.
Peptide Therapeutics: Contract API Manufacturing Market,
2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the bio-pharmaceutical
industry. The in-depth research, analysis and insights are driven by an
experienced leadership team which has gained many years of significant
experience in this sector. If you’d like help with your growing business needs,
get in touch at info@rootsanalysis.com
Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Comments
Post a Comment